Medpace Holdings (MEDP) | Stock Overview & Key Data
Medpace Holdings Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $628.92 on January 16, 2026
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Medpace Holdings
MEDP
|
11.72B Large-cap | 2.10% | 12.58% | 3.06% | -16.39% | -18.13% | 56.69% | 110.68% | 163.23% | 1,566.69% | 1,566.69% | 1,566.69% |
|
Thermo Fisher
TMO
|
174.55B Large-cap | 0.87% | 8.07% | 0.79% | -17.74% | -20.05% | 16.53% | -12.65% | -2.72% | 220.94% | 654.32% | 1,231.84% |
|
Danaher
DHR
|
126.39B Large-cap | -1.32% | 11.85% | -5.38% | -20.75% | -21.40% | -10.25% | -15.98% | -20.94% | 174.08% | 416.93% | 738.84% |
|
Idexx Laboratories
IDXX
|
44.66B Large-cap | 1.57% | 7.79% | -2.79% | -18.64% | -14.92% | 7.30% | 16.12% | -6.68% | 539.84% | 1,431.62% | 2,795.61% |
| 32.65B Large-cap | -2.11% | 3.78% | 7.87% | -3.22% | -4.70% | 10.90% | 7.19% | -10.46% | 186.24% | 282.67% | 444.17% | |
|
Waters
WAT
|
30.55B Large-cap | -1.54% | 8.67% | 23.36% | -7.18% | -6.34% | 3.87% | 32.07% | 3.74% | 165.28% | 286.07% | 736.74% |
Ownership & Short Interest
Calculate Your Medpace Holdings Investment Returns
Long-Term Investment Performance Analysis
Medpace Holdings stock price in Aug 2016 was $27.13, A $1,000.00 lump sum investment in Medpace Holdings made 9 years ago would be worth approximately $17,231.85 today, representing a exceptional return of 1,623.18%. This translates to an annualized return (CAGR) of 33.66%.
9 Years 9 Months Investment Scenario (Aug 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is MEDP's 52-week high and low?
- In the last 52 weeks, Medpace Holdings reached a high of $628.92 (on January 16, 2026) and a low of $294.07 (on June 18, 2025).
- What is the market cap and P/E ratio for MEDP?
- Curious about Medpace Holdings's size and valuation? Its market capitalization stands at 11.72B. When it comes to valuation, the P/E ratio (trailing twelve months) is 26.90, and the forward P/E (looking ahead) is 21.97.
- Does MEDP pay dividends? If so, what's the yield?
- As for dividends, Medpace Holdings isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Medpace Holdings's main competitors or similar companies to consider before investing?
When looking at Medpace Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.55B Healthcare Diagnostics & Research 16.53% -12.65% Danaher
DHR126.39B Healthcare Diagnostics & Research -10.25% -15.98% Idexx Laboratories
IDXX44.66B Healthcare Diagnostics & Research 7.30% 16.12% Agilent Technologies
A32.65B Healthcare Diagnostics & Research 10.90% 7.19% Waters
WAT30.55B Healthcare Diagnostics & Research 3.87% 32.07% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medpace Holdings Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Medpace Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 77.25%, the Debt to Equity ratio from the most recent quarter is 20.43, and its Gross Profit Margin stands at 27.78%.
- What is the recent revenue and earnings growth for MEDP?
- Looking at Medpace Holdings's growth, its revenue over the trailing twelve months (TTM) was $3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 26.50%, and quarterly earnings saw a YoY growth of 8.10%.
- How much of MEDP stock is held by insiders and institutions?
- Wondering who owns Medpace Holdings stock? Company insiders (like executives and directors) hold about 19.39% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 86.88%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.